Just another WordPress site

On the discounting of cannabis and money: Sensitivity to magnitude vs. delay

Sep 27, 2022

Abstract

Background

While using most drugs of abuse is associated with higher than control rates of delay discounting, cannabis use may be the exception. As such, between-commodity differences in delay discounting (i.e., money vs. cannabis) have not been thoroughly examined. We examined these between-commodity differences using modern analytic techniques to disentangle effects of subjects’ sensitivity to magnitude and delay as potential drivers of any obtained delay discounting rate differences.

Method

Fifty-eight college students (n = 33 cannabis users, n = 25 non-users) completed a monetary delay discounting task – with the cannabis users completing the cannabis problems questionnaire as well a delay discounting of cannabis task- in an on-campus laboratory.

Results

Responding between groups differed on the cannabis problems questionnaire, but not on delay discounting of monetary outcomes. Cannabis users, however, discounted cannabis at higher rates than money. Multilevel logistic regression revealed that these between-commodity delay discounting differences were due to subjects’ differential sensitivity to the magnitude of these two commodities, rather than sensitivity to delay to receiving these commodities.

Conclusions

Although differences in delay discounting rate were not obtained between students that did and did not use cannabis, cannabis users did discount cannabis at higher rates than they did money – suggesting considerable generality of the between commodity differences in delay discounting obtained elsewhere. The current between-commodity delay discounting differences appear to be driven by differential sensitivity to the reinforcer magnitudes presented in each task – a finding that awaits replication across other comparisons before statements about generality can be made.

Webmaster

Webmaster

Other Posts

Recommended Approaches to Evaluate Methodologies and Technologies for the Detection of Cannabis-Impaired Driving

In September 2023, New York State Department of Health (DOH) issued a Request for Information (RFI) regarding methodologies and technologies used for the detection and assessment of driving under-the-influence of cannabis (DUIC). The RFI purpose is to assist the DOH in assessing the current state of research on impairment due to cannabis ingestion, and to review current devices that can be used to detect impairment. Moreover, the DOH is seeking to identify research institutions in higher education that are currently performing this type of research.

read more

Maryland Medical Cannabis Patient Survey Report 2022

The Maryland Medical Cannabis Commission sponsored this survey and report from Cannabis Public Policy Consulting (CPPC) to examine patterns of use, perceptions of risk and benefit, and occurrence of high-risk
behaviors related to cannabis use in the medical cannabis patient population. More than 13,000 medical cannabis patients took part in the survey, which was conducted in September 2022, prior to the General Election referendum to legalize adult use in the state. A second, post referendum survey is planned for fall 2023.

read more

STAY INFORMED ON CPPC'S RESEARCH AND PROJECTS